What is contraction alkalosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraction Alkalosis: Pathophysiology and Management

Contraction alkalosis is a metabolic alkalosis that occurs when a reduction in extracellular fluid volume leads to increased bicarbonate concentration, characterized by elevated serum bicarbonate, decreased chloride, and increased arterial pH. 1

Pathophysiology

Contraction alkalosis develops through the following mechanisms:

  • Volume contraction: When extracellular fluid volume decreases (due to diuretics, vomiting, etc.), there is a proportionally greater loss of water and sodium chloride than bicarbonate
  • Chloride depletion: Low serum chloride (<98 mmol/L) is a hallmark finding 1
  • Renal compensation: Volume depletion activates the renin-angiotensin-aldosterone system, which promotes:
    • Sodium reabsorption in exchange for potassium and hydrogen ions
    • Enhanced bicarbonate reabsorption in the proximal tubule
    • Impaired ability of the kidneys to excrete excess bicarbonate

Laboratory Findings

Characteristic laboratory findings include:

  • Elevated serum bicarbonate (>26 mEq/L)
  • Decreased serum chloride (<98 mmol/L)
  • Decreased serum potassium (<3.5 mEq/L)
  • Elevated arterial pH (>7.45)
  • Low urinary chloride (<20 mEq/L) in volume depletion cases 1

Common Causes

  • Diuretic therapy: Particularly thiazides and loop diuretics
  • Vomiting or nasogastric suction: Loss of hydrochloric acid from the stomach
  • Hypovolemia: From any cause leading to extracellular fluid contraction
  • Medication interactions: As seen in the case of HCTZ and dicyclomine interaction 2

Clinical Presentation

Patients may present with:

  • Symptoms of volume depletion (postural dizziness, confusion, weakness)
  • Neuromuscular symptoms due to associated hypokalemia
  • Respiratory compensation (hypoventilation)
  • In severe cases: altered mental status, tetany, seizures

Management

Treatment should focus on addressing the underlying cause and correcting volume and electrolyte abnormalities:

  1. Volume repletion:

    • Isotonic saline (0.9% NaCl) is first-line therapy to correct both volume depletion and chloride deficit 1
    • This promotes renal bicarbonate excretion and suppresses the renin-angiotensin-aldosterone system
  2. Electrolyte correction:

    • Potassium chloride supplementation to correct hypokalemia (target 4.0-5.0 mEq/L) 1
    • Chloride replacement is crucial as it allows bicarbonate excretion
  3. Addressing the underlying cause:

    • Discontinue or reduce offending diuretics
    • For diuretic-dependent patients, consider adding potassium-sparing diuretics like spironolactone 1
  4. For severe or refractory cases:

    • Acetazolamide may be effective after correcting fluid and electrolyte abnormalities 3
    • In critically ill patients with kidney failure and severe alkalosis, consider low-bicarbonate dialysis 4

Special Considerations

  • Avoid rapid correction of electrolytes to prevent complications
  • Monitor serum electrolytes within 24 hours of initiating therapy 1
  • Check magnesium levels, as hypomagnesemia can perpetuate hypokalemia 1
  • Be cautious with potassium-sparing diuretics in patients with kidney dysfunction

Common Pitfalls

  • Treating the alkalosis without addressing the underlying cause
  • Using non-chloride potassium salts when hypochloremia is present
  • Failing to recognize medication interactions that can precipitate contraction alkalosis
  • Overlooking the need for ongoing monitoring of electrolytes during treatment

Contraction alkalosis is distinct from other forms of metabolic alkalosis in that it specifically results from a contracted extracellular fluid volume with proportionally greater retention of bicarbonate relative to water and chloride.

References

Guideline

Metabolic Alkalosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acetazolamide in the treatment of metabolic alkalosis in critically ill patients.

Heart & lung : the journal of critical care, 1991

Research

Treatment of severe metabolic alkalosis in a patient with congestive heart failure.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.